RPB grantees provide expert advice on glaucoma in the first event of the "Lunch & Learn" series.
This new media campaign shines a spotlight on the powerful benefits of vision research.
David Williams, PhD, is recognized for ground-breaking contributions to the field of vision research.
Dr. Chiang is a respected scientist, clinician and leader in vision research.
RPB is increasing both the amount of funding and the number of awards funded through its flagship grant in order to better support early-career vision scientists.
The organizations announce new grants to increase funding for innovative research from early-career vision scientists.
For the past 60 years, RPB has funded groundbreaking research to prevent, treat and cure all conditions that damage or destroy sight.
The NEI congratulates RPB on 60 years of accomplishments in a personal letter from the acting director.
Thank you to our donors for supporting the RPB CDA and launching more than 200 research careers!
Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.
Four new grantees received the Catalyst Awards for Innovative Research Approaches for AMD.
CDA founded 30 years ago as one of the few private sources of funding aimed specifically at early-career vision researchers.
Study from RPB-supported researchers at Duke University suggests loss of blood vessels in retina reflect changes in brain health.
A study from an RPB-supported researcher at Northwestern University School of Medicine could speed up the diagnosis of retinal diseases.
Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.
(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.
Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.
Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.
RPB and AUPO announce the 2018 recipient of the award focused on age-related macular degeneration.
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
Award recipients to use IRIS Registry database to conduct population-based studies.
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.